VERACYTE, INC.·4

Mar 16, 4:54 PM ET

Anderson Bonnie H 4

4 · VERACYTE, INC. · Filed Mar 16, 2023

Insider Transaction Report

Form 4
Period: 2023-03-15
Anderson Bonnie H
DirectorPresident & CEO
Transactions
  • Sale

    Common Stock

    2023-03-15$22.76/sh34,000$773,88853,967 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2023-03-1534,00068,117 total
    Exercise: $5.61Exp: 2026-03-14Common Stock (34,000 underlying)
  • Exercise/Conversion

    Common Stock

    2023-03-15$5.61/sh+34,000$190,74087,967 total
Holdings
  • Common Stock

    (indirect: By Trust)
    123,514
Footnotes (3)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022.
  • [F2]Represents weighted average sales price. Sale prices for the transactions range from $22.46 to $23.05. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F3]The option is fully vested.

Documents

1 file
  • 4
    wf-form4_167900006769897.xmlPrimary

    FORM 4